Dokumentasjon og artikler for utdyping
Ønsker du nærmere informasjon om de forskjellige studier eller sammendrag fra presentasjoner skal du sende en mail til salg@arcon-norway.no og oppgi hvilke data artikler eller sammendrag du er interessert i samt navn og adresse.
Følgende dokumentasjon foreligger:
•J. of Clinical & Experimental Obstetrics & Gynecology 2004;31(2): 123-126 "Efficacy and Safety of Standard versus Low Dose of Femarelle (Tofupill) for the Treatment of Menopausal Symptoms"; I. Yoles et al.
•British J. of Obstetrics & Gynecology 2005 (under publisering) “DT56a (Femarelle/Tofupill) Stimulates Bone Formation in Female Rats” ; Somjen, D., Yoles, I. et al.
• J. of Steroid Biochemistry & Molecular Biology 2003;86/1:93-98: “DT56a (Tofupill/Femarelle), selectively stimulates creatine kinase specific activity in skeletal tissues of rats but not in the uterus” Somjen D, Yoles I.
• Menopause 2003;10(6):522-525: "Tofupill/Femarelle (DT56a) – a New Phyto-Selective Estrogen Receptor Modulator-like Substance for the Treatment of Postmenopausal Bone Loss”; I. Yoles et al.
•J. of Endocrinological Investigation 2003;26:966-971: “DT56a stimulates creatine kinase specific activity in vascular tissues of rats”; Somjen D, Yoles I.
•Obstetrics & Gynecology, 2003:101(4S):98-99: “Selective Estrogen Receptor Modulation by Tofupill, a Unique Phyto-SERM for Menopausal Treatment”; Yoles I, Chayen B.A
• Obstetrics & Gynecology, 2002:99(4S):58S; “Phytoestrogens: A Time-Tested Solution for Menopausal Symptoms Revisited”; Yoles I, Kaplan B, et al.
• Endocrine Practice, 2002:8(2):151: “Tofupill, a New Potent Phytoestrogen for the Relief of Menopausal Symptoms; A Randomized Prospective Trial”; Yoles I, et al.
• J. of Gynecological Endocrinology, 2001:15(5S):130: “Tofupill, a new highly potential phytoestrogen as an alternative treatment for menopausal symptoms”; Kaplan B, Yoles I, et al
Til hovedside om Tofupill ®
Tilbake
|